FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3176528055> ?p ?o ?g. }

• W3176528055 abstract "The major cause of death in SARS-CoV-2 infected patients is due to de-regulation of the innate immune system and development of cytokine storm. SARS-CoV-2 infects multiple cell types in the lung, including macrophages, by engagement of its spike (S) protein on angiotensin converting enzyme 2 (ACE2) receptor. ACE2 receptor initiates signals in macrophages that modulate their activation, including production of cytokines and chemokines. IL-1R-associated kinase (IRAK)-M is a central regulator of inflammatory responses regulating the magnitude of TLR responsiveness. Aim of the work was to investigate whether SARS-CoV-2 S protein-initiated signals modulate pro-inflammatory cytokine production in macrophages. For this purpose, we treated PMA-differentiated THP-1 human macrophages with SARS-CoV-2 S protein and measured the induction of inflammatory mediators including IL6, TNFα, IL8, CXCL5, and MIP1a. The results showed that SARS-CoV-2 S protein induced IL6, MIP1a and TNFα mRNA expression, while it had no effect on IL8 and CXCL5 mRNA levels. We further examined whether SARS-CoV-2 S protein altered the responsiveness of macrophages to TLR signals. Treatment of LPS-activated macrophages with SARS-CoV-2 S protein augmented IL6 and MIP1a mRNA, an effect that was evident at the protein level only for IL6. Similarly, treatment of PAM3csk4 stimulated macrophages with SARS-CoV-2 S protein resulted in increased mRNA of IL6, while TNFα and MIP1a were unaffected. The results were confirmed in primary human peripheral monocytic cells (PBMCs) and isolated CD14+ monocytes. Macrophage responsiveness to TLR ligands is regulated by IRAK-M, an inactive IRAK kinase isoform. Indeed, we found that SARS-CoV-2 S protein suppressed IRAK-M mRNA and protein expression both in THP1 macrophages and primary human PBMCs and CD14+ monocytes. Engagement of SARS-CoV-2 S protein with ACE2 results in internalization of ACE2 and suppression of its activity. Activation of ACE2 has been previously shown to induce anti-inflammatory responses in macrophages. Treatment of macrophages with the ACE2 activator DIZE suppressed the pro-inflammatory action of SARS-CoV-2. Our results demonstrated that SARS-CoV-2/ACE2 interaction rendered macrophages hyper-responsive to TLR signals, suppressed IRAK-M and promoted pro-inflammatory cytokine expression. Thus, activation of ACE2 may be a potential anti-inflammatory therapeutic strategy to eliminate the development of cytokine storm observed in COVID-19 patients." @default.
• W3176528055 created "2021-07-05" @default.
• W3176528055 creator A5012111990 @default.
• W3176528055 creator A5017266325 @default.
• W3176528055 creator A5017540146 @default.
• W3176528055 creator A5031824191 @default.
• W3176528055 creator A5056598579 @default.
• W3176528055 creator A5059184320 @default.
• W3176528055 creator A5059959488 @default.
• W3176528055 creator A5076853480 @default.
• W3176528055 date "2021-06-23" @default.
• W3176528055 modified "2023-10-17" @default.
• W3176528055 title "SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages" @default.
• W3176528055 cites W1918903097 @default.
• W3176528055 cites W1981298734 @default.
• W3176528055 cites W1982321591 @default.
• W3176528055 cites W1985181577 @default.
• W3176528055 cites W1997479533 @default.
• W3176528055 cites W2008054951 @default.
• W3176528055 cites W2037985064 @default.
• W3176528055 cites W2054356692 @default.
• W3176528055 cites W2055736315 @default.
• W3176528055 cites W2091671824 @default.
• W3176528055 cites W2124460853 @default.
• W3176528055 cites W2162360300 @default.
• W3176528055 cites W2163610648 @default.
• W3176528055 cites W2167384912 @default.
• W3176528055 cites W2512171222 @default.
• W3176528055 cites W2513547424 @default.
• W3176528055 cites W2565647833 @default.
• W3176528055 cites W2579499065 @default.
• W3176528055 cites W2756541052 @default.
• W3176528055 cites W2790198199 @default.
• W3176528055 cites W2918068185 @default.
• W3176528055 cites W3001118548 @default.
• W3176528055 cites W3004318991 @default.
• W3176528055 cites W3004348779 @default.
• W3176528055 cites W3007104924 @default.
• W3176528055 cites W3008394341 @default.
• W3176528055 cites W3008827533 @default.
• W3176528055 cites W3009335299 @default.
• W3176528055 cites W3009885589 @default.
• W3176528055 cites W3009912996 @default.
• W3176528055 cites W3010955108 @default.
• W3176528055 cites W3011134208 @default.
• W3176528055 cites W3013893688 @default.
• W3176528055 cites W3014333693 @default.
• W3176528055 cites W3014912119 @default.
• W3176528055 cites W3016263512 @default.
• W3176528055 cites W3017331996 @default.
• W3176528055 cites W3019598142 @default.
• W3176528055 cites W3020655115 @default.
• W3176528055 cites W3021577931 @default.
• W3176528055 cites W3023982717 @default.
• W3176528055 cites W3025292139 @default.
• W3176528055 cites W3036466450 @default.
• W3176528055 cites W3038622946 @default.
• W3176528055 cites W3041206342 @default.
• W3176528055 cites W3048875944 @default.
• W3176528055 cites W3085500933 @default.
• W3176528055 cites W3091085673 @default.
• W3176528055 cites W3124454689 @default.
• W3176528055 cites W3126538466 @default.
• W3176528055 doi "https://doi.org/10.3389/fimmu.2021.683800" @default.
• W3176528055 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8261299" @default.
• W3176528055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34248968" @default.
• W3176528055 hasPublicationYear "2021" @default.
• W3176528055 type Work @default.
• W3176528055 sameAs 3176528055 @default.
• W3176528055 citedByCount "36" @default.
• W3176528055 countsByYear W31765280552021 @default.
• W3176528055 countsByYear W31765280552022 @default.
• W3176528055 countsByYear W31765280552023 @default.
• W3176528055 crossrefType "journal-article" @default.
• W3176528055 hasAuthorship W3176528055A5012111990 @default.
• W3176528055 hasAuthorship W3176528055A5017266325 @default.
• W3176528055 hasAuthorship W3176528055A5017540146 @default.
• W3176528055 hasAuthorship W3176528055A5031824191 @default.
• W3176528055 hasAuthorship W3176528055A5056598579 @default.
• W3176528055 hasAuthorship W3176528055A5059184320 @default.
• W3176528055 hasAuthorship W3176528055A5059959488 @default.
• W3176528055 hasAuthorship W3176528055A5076853480 @default.
• W3176528055 hasBestOaLocation W31765280551 @default.
• W3176528055 hasConcept C108634530 @default.
• W3176528055 hasConcept C11988809 @default.
• W3176528055 hasConcept C13373296 @default.
• W3176528055 hasConcept C136449434 @default.
• W3176528055 hasConcept C164027704 @default.
• W3176528055 hasConcept C170217031 @default.
• W3176528055 hasConcept C170493617 @default.
• W3176528055 hasConcept C17991360 @default.
• W3176528055 hasConcept C187316574 @default.
• W3176528055 hasConcept C203014093 @default.
• W3176528055 hasConcept C204258353 @default.
• W3176528055 hasConcept C2776914184 @default.
• W3176528055 hasConcept C2778513237 @default.
• W3176528055 hasConcept C2778690821 @default.
• W3176528055 hasConcept C54355233 @default.
• W3176528055 hasConcept C55493867 @default.
• W3176528055 hasConcept C68324877 @default.

• next